ABEO — Abeona Therapeutics Share News
0.000.00%
Last trade - 00:00- $260.76m
- $128.92m
- $5.82m
U.S. STOCKS ON THE MOVE-Keurig Dr Pepper, Ardelyx, Vertiv
U.S. STOCKS ON THE MOVE-Broadcom, JPMorgan, Enpro
U.S. STOCKS ON THE MOVE-Bloom Energy, Argan, Endra Life Sciences
Abeona rises as US FDA picks its eye disease gene therapy for pilot program
Brief: Abeona Therapeutics Announces New Employee Inducement
Brief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Abeona Therapeutics Q2 net income beats estimates on PRV sale, sees profitability in H1 2026
Abeona Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Investar, Steel Dynamics, Axos Financial
U.S. STOCKS ON THE MOVE-Tesla, ABM Industries, Regeneron
U.S. STOCKS ON THE MOVE-Zevra Therapeutics, Abeona Therapeutics, Greenbrier
Abeona Therapeutics rises on FDA priority review voucher sale for $155 million
Brief: Abeona Therapeutics Announces Option Exercise By Beacon Therapeutics For Novel AAV204 Capsid For Ophthalmology Gene Therapy
Brief: Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Health Rounds: Inhaled insulin as good as injection for children at mealtime
Brief: Abeona Therapeutics Announces New Employee Inducement Grants
Abeona Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Abeona Therapeutics And Lurie Children's Open First Center For Zevaskyntm Gene Therapy